NEPH CIK: 1196298

Nephros Inc.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
13.6
FY22:
8.26
FY23:
8.41
FY24:
8.30
FY25:
11.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
4.02
FY22:
2.74
FY23:
3.46
FY24:
2.91
FY25:
2.42
Total assets
Change from FY21 to FY25
millions USD
FY21:
17.7
FY22:
11.0
FY23:
11.9
FY24:
11.2
FY25:
13.6

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
2.39
FY22:
1.41
FY23:
2.11
FY24:
1.56
FY25:
2.77
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.51
FY22:
0.71
FY23:
1.39
FY24:
1.06
FY25:
0.67
(positive)
Change from FY21 to FY25
millions USD
FY21:
11.7
FY22:
5.59
FY23:
8.36
FY24:
8.59
FY25:
10.2
Total liabilities & equity
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
11.9
FY24:
11.2
FY25:
13.6

All amounts in millions USD Data source:SEC EDGAR